Literature DB >> 19074842

MicroRNAs and cancer: past, present, and potential future.

Kristen M Nelson1, Glen J Weiss.   

Abstract

MicroRNAs (miRNAs) are a class of small RNAs that have revealed a new level of gene regulation in the cell. After being processed by Drosha and Dicer RNase III endonucleases, mature miRNAs can inhibit the translation of mRNA by directing a RNA-induced silencing complex (RISC) to the target mRNA. miRNAs are making an impact in our understanding of cancer biology. Acting as either tumor suppressors or oncogenes, miRNAs regulate several genes known to play important roles in cancer. With the discovery of miRNAs comes the need for new techniques to study their activity. Bioinformatic tools can be used to predict mRNA targets of miRNA, but validation of miRNA regulation of predicted targets is imperative. miRNAs are differentially expressed in normal and tumor cells as well as between tumor subtypes. These differences may be useful as prognostic and predictive markers in cancer patients. The study of miRNAs holds much promise for improving diagnosis and treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19074842     DOI: 10.1158/1535-7163.MCT-08-0586

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  111 in total

Review 1.  Role of microRNAs in lymphoid biology and disease.

Authors:  Muller Fabbri; Carlo M Croce
Journal:  Curr Opin Hematol       Date:  2011-07       Impact factor: 3.284

Review 2.  DNA methylation and microRNAs in cancer.

Authors:  Xiang-Quan Li; Yuan-Yuan Guo; Wei De
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

3.  Discovery and characterization of novel microRNAs during endothelial differentiation of human embryonic stem cells.

Authors:  Jung Ki Yoo; Jumi Kim; Seong-Jun Choi; Hye Min Noh; Young Do Kwon; Hanna Yoo; Hyo Seon Yi; Hyung Min Chung; Jin Kyeoung Kim
Journal:  Stem Cells Dev       Date:  2012-02-07       Impact factor: 3.272

4.  Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells.

Authors:  Tissa T Manavalan; Yun Teng; Savitri N Appana; Susmita Datta; Theodore S Kalbfleisch; Yong Li; Carolyn M Klinge
Journal:  Cancer Lett       Date:  2011-09-10       Impact factor: 8.679

Review 5.  Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma.

Authors:  Akira Kurozumi; Yusuke Goto; Atsushi Okato; Tomohiko Ichikawa; Naohiko Seki
Journal:  J Hum Genet       Date:  2016-06-30       Impact factor: 3.172

6.  Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer.

Authors:  Neveen Abd El Moneim Hussein; Zenat A El Kholy; Medhat M Anwar; Mohamed A Ahmad; Shaymaa M Ahmad
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-15       Impact factor: 4.553

7.  MicroRNA-205 inhibits tumor cell migration through down-regulating the expression of the LDL receptor-related protein 1.

Authors:  Heesang Song; Guojun Bu
Journal:  Biochem Biophys Res Commun       Date:  2009-08-08       Impact factor: 3.575

8.  MicroRNA-1 (miR-1) inhibits chordoma cell migration and invasion by targeting slug.

Authors:  Eiji Osaka; Xiaoqian Yang; Jacson K Shen; Pei Yang; Yong Feng; Henry J Mankin; Francis J Hornicek; Zhenfeng Duan
Journal:  J Orthop Res       Date:  2014-04-24       Impact factor: 3.494

9.  miR-216a-5p acts as an oncogene in renal cell carcinoma.

Authors:  Peijie Chen; Jing Quan; Lu Jin; Canbin Lin; Weijie Xu; Jinling Xu; Xin Guan; Zebo Chen; Liangchao Ni; Shangqi Yang; Yun Chen; Yongqing Lai
Journal:  Exp Ther Med       Date:  2018-02-20       Impact factor: 2.447

10.  MicroRNAs: tools for cancer diagnostics.

Authors:  T Paranjape; F J Slack; J B Weidhaas
Journal:  Gut       Date:  2009-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.